TEVA
Teva Pharmaceutical Industries Limited · NYSE · Healthcare · USD · 10-K for 2025, filed 2026-02-03
Figures on this page computed 2026-11-08 13:00 UTC
Last close
41.85USD
Market data, 2026-11-04
Except where said otherwise: 10-K for 2025, filed 2026-02-03
34.6xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-034532
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-03
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-034532
- Reported in
- USD
- 10-K for 2025, filed 2026-02-03
- 10-K for 2025, filed 2026-02-03
- 10-K for 2025, filed 2026-02-03
- 10-Q for 2025, filed 2026-11-03
- 10-K for 2025, filed 2026-02-03
- 10-Q for 2025, filed 2026-11-03
8.2%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-034532
- Reported in
- USD
- 10-K for 2025, filed 2026-02-03
- 10-K for 2025, filed 2026-02-03
6.7%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-034532
- Reported in
- USD
- 10-K for 2025, filed 2026-02-03
- 10-K for 2025, filed 2026-02-03
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-034532
- Reported in
- USD
- 10-K for 2025, filed 2026-02-03
- 10-Q for 2025, filed 2026-11-03
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Safety is the furthest below its sector's middle: 0.29 against 0.53 on the market's range.
- Growth0.7%55 of 100, above its sector
- Returns on capital17.8%76 of 100, above its sector
- Margins51.8%67 of 100, above its sector
- Price34.6x26 of 100, below its sector
- Safety1.0429 of 100, below its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Five bars, one line
lens 7 of 9Each against its own average
5 of 5 readExcept where said otherwise: 10-K for 2025, filed 2026-02-03
- Sales0.98x
Its own average over 10 years, 17.66B.
- Profit-0.54x
Its own average over 10 years, -2.59B.
- Free cash flow1.04x
Its own average over 10 years, 1.10B.
- Debt0.27x
Its own average over 10 years, 9.02B.
- Price2.47x
Its own average over 11 years, 17. Market data, 2026-11-04
Profit is furthest from its own average, at -0.54 times.
Sales is 0.98 times its own 10-year average; Profit is -0.54 times its own 10-year average; Free cash flow is 1.04 times its own 10-year average; Debt is 0.27 times its own 10-year average; Price is 2.47 times its own 11-year average.
Every figure in this lens
Except where said otherwise: 10-K for 2025, filed 2026-02-03
Sales against its own 10-year average0.98
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001193125-26-034532
- Reported in
- USD
Profit against its own 10-year average-0.54
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001193125-26-034532
- Reported in
- USD
Free cash flow against its own 10-year average1.04
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001193125-26-034532
- Reported in
- USD
Debt against its own 10-year average0.27
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001193125-26-034532
- Reported in
- USD
Price against its own 11-year average2.47Market data, 2026-11-04
- Source
- market
- Taken on
- 2026-11-04
- Reported in
- USD